Oncolytics Biotech, Inc (NASDAQ:ONCY)’s traded shares stood at 0.66 million during the last session, with the company’s beta value hitting 1.29. At the close of trading, the stock’s price was $0.99, to imply a decrease of -0.71% or -$0.01 in intraday trading. The ONCY share’s 52-week high remains $1.53, putting it -54.55% down since that peak but still an impressive 28.28% since price per share fell to its 52-week low of $0.71. The company has a valuation of $76.59M, with an average of 0.87 million shares in intraday trading volume over the past 10 days and average of 600.58K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Oncolytics Biotech, Inc (ONCY), translating to a mean rating of 1.14. Of 1 analyst(s) looking at the stock, 0 analyst(s) give ONCY a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 1 recommend it as a Buy.
Oncolytics Biotech, Inc (NASDAQ:ONCY) trade information
After registering a -0.71% downside in the last session, Oncolytics Biotech, Inc (ONCY) has traded red over the past five days. The 5-day price performance for the stock is 11.99%, and 4.62% over 30 days. With these gigs, the year-to-date price performance is -26.39%. Short interest in Oncolytics Biotech, Inc (NASDAQ:ONCY) saw shorts transact 2.81 million shares and set a 3.51 days time to cover.
Oncolytics Biotech, Inc (ONCY) estimates and forecasts
Looking at statistics comparing Oncolytics Biotech, Inc share performance against respective industry, we note that the company has underperformed competitors. Oncolytics Biotech, Inc (ONCY) shares are 0.38% up over the last 6 months, with its year-to-date growth rate lower than industry average at 3.33% against 16.60%.
ONCY Dividends
Oncolytics Biotech, Inc has its next earnings report out in January. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Oncolytics Biotech, Inc (NASDAQ:ONCY)’s Major holders
Oncolytics Biotech, Inc insiders hold 3.82% of total outstanding shares, with institutional holders owning 1.76% of the shares at 1.83% float percentage. In total, 1.76% institutions holds shares in the company, led by INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC. As of 2024-06-30, the company held over 0.2 million shares (or 0.2637% of shares), all amounting to roughly $0.2 million.
The next major institution holding the largest number of shares is SEEDS INVESTOR LLC with 0.19 million shares, or about 0.2524% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.19 million.
